Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 10-2005 | 10-2004 | 10-2003 | 10-2002 | 10-2001 | |
| Sales | 1,128,900 | 733,900 | 579,800 | 819,500 | 2,402,800 |
| Cost of Goods | 703,700 | 433,400 | 371,800 | 656,300 | 1,677,800 |
| Gross Profit | 425,200 | 300,500 | 208,000 | 163,200 | 725,000 |
| Operating Expenses | 340,700 | 276,900 | 262,800 | 901,800 | 1,757,100 |
| Operating Income | 85,200 | 24,000 | -54,000 | -738,300 | -1,031,300 |
| Other Income | 20,800 | 9,600 | 9,100 | 6,400 | -889,400 |
| Pre-tax Income | 106,000 | 33,600 | -44,900 | -731,900 | -1,920,700 |
| Income Tax | 7,200 | 2,000 | -5,100 | 248,300 | -633,000 |
| Net Income Continuous | 98,800 | 31,600 | -39,800 | -980,200 | -1,287,700 |
| Net Income Discontinuous | 11,900 | -15,200 | -36,900 | -164,800 | N/A |
| Net Income | $110,700 | $16,400 | $-76,700 | $-1,145,000 | $-1,287,700 |
| EPS Basic Total Ops | 0.95 | 0.14 | -0.67 | -10.08 | -11.48 |
| EPS Basic Continuous Ops | 0.85 | 0.27 | -0.35 | -8.61 | -11.45 |
| EPS Basic Discontinuous Ops | 0.10 | -0.13 | -0.32 | -1.47 | N/A |
| EPS Diluted Total Ops | 0.91 | 0.14 | -0.67 | -10.08 | -11.48 |
| EPS Diluted Continuous Ops | 0.82 | 0.27 | -0.35 | -8.61 | -11.45 |
| EPS Diluted Discontinuous Ops | 0.09 | -0.13 | -0.32 | -1.47 | N/A |
| EBITDA(a) | $152,100 | $64,900 | $-600 | $-637,500 | $-833,500 |